GCC In-Vitro Diagnostic Devices Market Report by End-User (Hospital-Based Centers, Diagnostics Chains, Standalone Centers, and Others), Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), and Country 2026-2034

GCC In-Vitro Diagnostic Devices Market Report by End-User (Hospital-Based Centers, Diagnostics Chains, Standalone Centers, and Others), Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), and Country 2026-2034

Report Format: PDF+Excel | Report ID: SR112025A1088

Market Overview:

The GCC in-vitro diagnostic devices market size reached USD 1,334.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,850.8 Million by 2034, exhibiting a growth rate (CAGR) of 3.71% during 2026-2034.

Report Attribute 
Key Statistics
Base Year
2025
Forecast Years
2026-2034
Historical Years
2020-2025
Market Size in 2025
USD 1,334.0 Million
Market Forecast in 2034
USD 1,850.8 Million
Market Growth Rate 2026-2034 3.71%

Access the full market insights report Request Sample

In-vitro diagnostics (IVD) refer to the clinical tests conducted on different bodily samples, such as urine, tissue and blood, to detect diseases and infections. These tests are also employed to monitor the health conditions of patients undergoing different treatments and the effectiveness of therapeutic procedures. Various devices can be used individually or in combination with each other for in-vitro diagnosis, including specimen receptacles, calibrators, reagents and control materials. In the GCC countries, IVD devices have gained traction on account of the aging population, the expanding healthcare sector and the establishment of standalone centers, independent diagnostics chains and academic institutes.

The easy access to better diagnostics and healthcare facilities represents the primary factor impelling the growth of the market in the GCC region. This is facilitated by the increasing insurance penetration rate under the Mandatory Health Insurance (MHI) schemes in the GCC countries. Besides this, a large portion of the deaths in the GCC countries is caused due to chronic diseases that are generally associated with lifestyle factors, including tobacco consumption, unhealthy diets and sedentary schedules. Consequently, the growing health consciousness among consumers has led to a significant rise in the number of people seeking diagnostic services at regular intervals to avoid these conditions. Additionally, individuals have increased their medical health spending due to inflating disposable incomes, which has further influenced the market growth. Moreover, the governments of several GCC countries have developed various health awareness programs and strategies. They have also shifted their focus toward promoting specialized care and services and are increasing investments in the purchase of devices used in medical examinations. Other factors, such as the rising number of expatriates and growing investments in healthcare infrastructure, are further driving the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the GCC in-vitro diagnostic devices market report, along with forecasts at the regional and country level from 2026-2034. Our report has categorized the market based on end-user and application.

Breakup by End-user:

GCC In-Vitro Diagnostic Devices Market

To get detailed segment analysis of this market Request Sample

  • Hospital-Based Centers
  • Diagnostics Chains
  • Standalone Centers
  • Others
     

At present, in-vitro diagnostic devices are majorly used in hospital-based centers.

Breakup by Application:

  • Infectious Diseases
  • Diabetes
  • Blood Test
  • Nephrology
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Others
     

Presently, infectious diseases exhibit a clear dominance in the market.

Country Insights:

GCC In-Vitro Diagnostic Devices Market By Country

To get detailed regional analysis of this market Request Sample

  • Saudi Arabia
  • United Arab Emirates
  • Kuwait
  • Qatar
  • Oman
  • Bahrain
     

Country-wise, Saudi Arabia holds the leading position in the market.

Competitive Landscape:

The competitive landscape of the market has been examined in the report with the detailed profiles of the key players operating in the industry.

Report Coverage:

Report Features Details
Base Year of the Analysis 2025
Historical Period 2020-2025
Forecast Period 2026-2034
Units Million USD
Segment Coverage End User, Application, Country
Countries Covered Saudi Arabia, United Arab Emirates, Qatar, Oman, Kuwait, Bahrain
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the GCC in-vitro diagnostic devices market performed so far and how will it perform in the coming years?
  • What are the key regions in the market?
  • What has been the impact of COVID-19 on the GCC in-vitro diagnostic devices market?
  • What are the various application segments in the market?
  • What are the major end-use sectors in the market?
  • What are the various stages in the value chain of the market?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the GCC in-vitro diagnostic devices market and who are the key players?
  • What is the degree of competition in the market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
GCC In-Vitro Diagnostic Devices Market Report by End-User (Hospital-Based Centers, Diagnostics Chains, Standalone Centers, and Others), Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), and Country 2026-2034
Purchase Options Year End
sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials